Patterson Cos. (NASDAQ: PDCO) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.13 billion.

Patterson Cos. sees FY2016 EPS of $2.40-$2.50, versus the consensus of $2.44.

“Executing on our strategic plan and focusing on operational discipline enabled Patterson to close fiscal 2015 with healthy contributions from all three of our businesses,” said Scott Anderson, chairman and chief executive officer. “We are encouraged by the momentum we are seeing in all of our business units. As we work to complete the acquisition of Animal Health International and the potential sale of our Medical unit, we are confident that the transformation we are pursuing for Patterson will lead to long-term growth and success.”

For earnings history and earnings-related data on Patterson Cos. (PDCO) click here.